Drug IndexEntyvio (vedolizumab)
Billing
Code: J3380
Description: Injection, vedolizumab
Unit: 1 MG
Payment: $21.853
Pay quarter: Q2 2024
Covered in Part D: No
Drug Cost
Calculate drug cost and reimbursement
Total WAC:
$8,666.58Total Reimbursement:
$6,555.90(ASP: $6,184.81, Margin: $371.09)
.
.# Units to bill:
300Dosage & Frequency
Ulcerative Colitis (UC)
Crohn's Disease (CD)
Induction:
• 300mg IV at weeks 0, 2, and 6
Maintenance:
• 300mg IV every 8 weeks
Crohn's Disease (CD)
Induction:
• 300mg IV at weeks 0, 2, and 6
Maintenance:
• 300mg IV every 8 weeks
Billable NDCs
64764-0300-20
ENTYVIO (TAKEDA PHARMACEUTICALS AMERICA, INC.)
300 MG
Prior Authorization
Resources